Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Lobe Sciences Ltd (LOBE.CN)

Lobe Sciences Ltd (LOBE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lobe Sciences Ltd 1771 Robson Street No. 1614 Vancouver BC V6G 3B7 CAN

https://www.lobesciences.com P: 949-505-5623

Sector:

N/A

Description:

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Key Statistics

Overview:

Market Capitalization, $K 6,762
Shares Outstanding, K 193,198
Annual Sales, $ 136 K
Annual Net Income, $ -4,421 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -984 K
60-Month Beta 0.17
% of Institutional Shareholders 0.31%

Growth:

1-Year Return 75.00%
3-Year Return -30.00%
5-Year Return -96.35%
5-Year Revenue Growth -29.35%

Per-Share Information:

Most Recent Earnings -0.01 on 07/30/25
Next Earnings Date N/A
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -25.14%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 06/10/22

LOBE.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -106.68%
Profit Margin % -3,245.64%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar